溶瘤病毒的公司感觉这个算最好了。最麻烦是现金只够6个季度。pd1后复发黑色素瘤的二期数据还可...查看全文
Replimune Group(REPL)02-08 21:15
$Replimune Group(REPL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001737953-24-000004 Act: 34 Size: 8 MB 网页链接查看全文
Replimune Group(REPL)04-04 08:05
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043256 Size: 7 KB 网页链接查看全文
Replimune Group(REPL)04-04 08:05
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043253 Size: 7 KB 网页链接查看全文
Replimune Group(REPL)02-14 20:25
$Replimune Group(REPL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-035048 Act: 34 Size: 52 KB 网页链接查看全文
Replimune Group(REPL)04-04 08:05
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043248 Size: 5 KB 网页链接查看全文
Replimune Group(REPL)04-04 08:05
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043252 Size: 5 KB 网页链接查看全文
Replimune Group(REPL)02-14 23:05
$Replimune Group(REPL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000080255-24-000735 Act: 34 Size: 6 KB 网页链接查看全文
Replimune Group(REPL)02-15 05:35
$Replimune Group(REPL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023781 Act: 34 Size: 81 KB 网页链接查看全文
Replimune Group(REPL)02-08 21:15
$Replimune Group(REPL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-011951 Act: 34 Size: 288 KB 网页链接查看全文
JZee03-27 09:20
$Replimune Group(REPL)$ 管理层大地震了。首席策略官升任CEO,原CEO、联合创始人任董事长。原首席研发官、联合创始人变成顾问和首席科学家,感觉架空了。原首席运营官退休。多个C级别的经理滚蛋。
溶瘤病毒的公司感觉这个算最好了。最麻烦是现金只够6个季度。pd1后复发黑色素瘤的二期数据还可...查看全文
美股滚雪球2023-08-01 08:54
$Replimune Group(REPL)$ 和$因塞特医疗(INCY)$ 达成协议,研究前者的溶瘤免疫疗法RP1与后者的口服PD-L1抑制剂INCB99280联合治疗皮肤鳞状细胞癌(CSCC)。
$百济神州-U(SH688235)$查看全文
牛唐2021-12-15 11:31
$Synthetic Biologics(SYN)$ 宣布收购VCN Biosciences(一家位于西班牙的私营临床阶段免疫肿瘤公司)。
VCN生物科学公司目前正在开发一种用于静脉注射的溶瘤腺病毒(OV)平台,主要资产VCN-01已经完成了临床1期研究,包括胰腺癌、头颈部鳞状细胞癌和视网膜母细胞瘤患者。
交易的对价为470...查看全文
矫首遐观2021-11-17 16:10
$Oncorus(ONCR)$ 这家公司心蛮大的,入组临床的大部分是晚期转移的未线病人,黑色素瘤5人,3人用过二种单抗,2人用过一种单抗。三阴性乳腺癌经历过7种疗法,肛门癌6种疗法,头颈癌4种疗法,临床阶段共有三位患者因病情进展死亡。~真不知道是不是特意挑选未线病人来检验安全性、耐受性,还是因为疫...查看全文
矫首遐观2021-10-27 12:32
$Oncorus(ONCR)$ 之所以对溶瘤病毒感兴趣,原因在于病毒本身就是种药物,同时病毒又可以成为其他药物的载体,这种双重属性目前是其他药物所不具备的,后面就看如何充分挖掘这种功能了。$Replimune Group(REPL)$ $Candel Therapeutics(CADL)$查看全文
美股滚雪球2021-10-17 16:52
投行BTIG的评级:
1、$Replimune Group(REPL)$ 买入,目标价60美元;
2、$OncoSec医疗(ONCS)买入,目标价为10美元。
3、$Nuvation Bio(NUVB)买入,目标价为16美元。
4、$Mersana Therapeutics(MRSN)$ 买入评级,目标价32美元。
5、$Macrogenics(MGNX)买入评级,目标价为50美元...查看全文
矫首遐观2021-09-30 08:05
$Oncorus(ONCR)$ MASTERKEY-265的1b数据一般,致使同样用疱疹病毒的oncr股价继续受压,但我认为oncr-177所使用的技术远胜于T-vec也比$Replimune Group(REPL)$ 的PR3更先进,只好含泪再加仓10%查看全文
矫首遐观2021-08-13 13:22
$Oncorus(ONCR)$ 觉得未来可以对标下$Replimune Group(REPL)$ ,看看一期数据公布后会到多少?次新股中目前就决定死守你和$Sqz Biotechnologies(SQZ)$ 了。查看全文
牛唐2021-05-06 10:45
医药板块观察(2021.05.05)
本期内容提示:
1、疫苗专利豁免,疫苗股是否有抄底机会?
2、TCON财报后下跌,作为中国药企出海的合作伙伴,是否有配置价值?
3、核心仓位$Replimune Group Inc.(REPL)$ 缘何大涨,后续如何操作?
$BioNTech(BNTX)$ $复星医药(SH600196)$查看全文
$Replimune Group(REPL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000080255-24-000833 Act: 34 Size: 6 KB 网页链接
$Replimune Group(REPL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000093751-24-000577 Act: 34 Size: 10 KB 网页链接
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043246 Size: 7 KB 网页链接
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043248 Size: 5 KB 网页链接
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043247 Size: 5 KB 网页链接
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043250 Size: 7 KB 网页链接
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043251 Size: 5 KB 网页链接
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043252 Size: 5 KB 网页链接
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043253 Size: 7 KB 网页链接
$Replimune Group(REPL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043255 Size: 5 KB 网页链接